A story from our wider community
Luke Schmaedeke:
A family’s path to specialized care
An archived NIH Record profile follows a Minnesota family from an unexpected finding to specialist care, with a patient advocate helping them find their way.

An unexpected finding
Luke Schmaedeke’s family had already learned that HLRCC was part of their family history. In the account published by NIH Record in August 2021, his first kidney MRI at Mayo Clinic revealed a small mass. His mother, Jen, described the shock and uncertainty that followed.
The report traces the family’s awareness of HLRCC to a research study involving Luke’s grandmother. Later, Luke had genetic testing while accompanying his older sister to an appointment and learned that he, too, had HLRCC.
Finding an advocate
Before a planned operation to remove Luke’s entire right kidney, Jen searched online and found the HLRCC Family Alliance. She connected with Bruce Lee, whose son Andrew had founded Driven To Cure. Bruce encouraged the family to seek another opinion. Two weeks later, Jen and Luke arrived at NIH.
For Jen, that support was personal as well as practical. Someone who understood the experience was helping the family find specialists and navigate a difficult decision.
A decision about his care
The NIH team recommended surgery, although imaging had not confirmed whether the mass was malignant. The report describes Luke’s hesitation and further conversations with the team before he agreed to the operation.
NIH surgeon Dr. Mark Ball performed a partial nephrectomy. According to the profile, the operation preserved about 85 percent of Luke’s kidney. Ball described the tumor as confined and caught early enough.
“This is definitely a knowledge is power situation”
— Dr. Mark Ball, quoted by Dana Talesnik in NIH Record, 2021
Returning to everyday life
NIH Record reported that Luke returned to class ten days after surgery and later returned to pitching for his college baseball team that spring. Those are the outcomes described in the 2021 account, not an update on his health today.
The profile also connects the family’s experience with Andrew Lee’s participation in research and the Lee family’s advocacy. Its focus is not only on advances in care, but on the people who helped another family reach that care.
In their own words
Adapted from Dana Talesnik’s August 6, 2021 article, “Advances in Care Help Save Young HLRCC Patient.” The link opens a Wayback Machine copy captured January 17, 2025 at 9:07 PM MST (capture ID 20250118040736).
Read the archived original at NIH Record (archived January 17, 2025 MST) →